News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
6,763 Results
Type
Article (58)
Press Release (6705)
Section
Business (2605)
Career Advice (5)
Deals (383)
Drug Development (1318)
FDA (227)
Job Trends (412)
News (4256)
Policy (225)
Tag
Academia (8)
Allergies (5)
Alliances (90)
ALS (3)
Alzheimer's disease (51)
Approvals (257)
Artificial intelligence (3)
Autoimmune disease (1)
Bankruptcy (1)
Best Places to Work (463)
Biosimilars (2)
Bladder cancer (9)
Breast cancer (20)
Cancer (168)
Cardiovascular disease (16)
Career advice (4)
CAR-T (2)
Cell therapy (6)
Cervical cancer (4)
Clinical research (1379)
Collaboration (7)
Compensation (4)
COVID-19 (11)
CRISPR (3)
C-suite (1)
Data (229)
Depression (1)
Diabetes (10)
Diagnostics (66)
Drug discovery (2)
Drug pricing (1)
Duchenne muscular dystrophy (2)
Earnings (2867)
Events (705)
Executive appointments (1)
FDA (343)
Frontotemporal dementia (1)
Funding (9)
Gene editing (3)
Generative AI (1)
Gene therapy (11)
GLP-1 (14)
Government (25)
Guidances (45)
Healthcare (167)
HIV (3)
Immunology and inflammation (2)
Indications (4)
Infectious disease (18)
Inflammatory bowel disease (3)
Influenza (2)
Intellectual property (2)
IPO (324)
IRA (1)
Job creations (6)
Job search strategy (4)
Kidney cancer (2)
Layoffs (3)
Legal (11)
Liver cancer (1)
Lung cancer (47)
Lymphoma (16)
Manufacturing (2)
MASH (4)
Medical device (206)
Medtech (206)
Mergers & acquisitions (73)
Metabolic disorders (16)
Multiple sclerosis (7)
NASH (2)
Neurodegenerative disease (2)
Neuroscience (81)
NextGen: Class of 2025 (17)
Non-profit (20)
Obesity (3)
Opinion (1)
Ovarian cancer (2)
Pain (1)
Pancreatic cancer (3)
Parkinson's disease (10)
Patents (1)
Patient recruitment (2)
Peanut (5)
People (30)
Phase I (200)
Phase II (412)
Phase III (802)
Pipeline (165)
Policy (1)
Postmarket research (86)
Preclinical (31)
Prostate cancer (3)
Radiopharmaceuticals (7)
Rare diseases (10)
Real estate (2)
Regulatory (279)
Reports (2)
Research institute (10)
Resumes & cover letters (2)
Rett syndrome (2)
RSV (4)
Schizophrenia (6)
Series B (2)
Sickle cell disease (1)
Spinal muscular atrophy (1)
Sponsored (1)
Startups (4)
Vaccines (13)
Women's health (1)
Date
Today (1)
Last 7 days (14)
Last 30 days (49)
Last 365 days (903)
2025 (686)
2024 (777)
2023 (760)
2022 (807)
2021 (873)
2020 (610)
2019 (414)
2018 (359)
2017 (269)
2016 (133)
2015 (188)
2014 (114)
2013 (69)
2012 (93)
2011 (99)
2010 (92)
Location
Africa (2)
Arizona (6)
Asia (508)
Australia (27)
California (215)
Canada (41)
China (29)
Colorado (2)
Connecticut (10)
Delaware (34)
Europe (1219)
Florida (30)
Georgia (8)
Illinois (16)
India (1)
Indiana (22)
Iowa (1)
Japan (19)
Kansas (5)
Maryland (29)
Massachusetts (139)
Michigan (5)
Minnesota (11)
Missouri (2)
Nevada (2)
New Jersey (141)
New York (56)
North Carolina (23)
Northern California (132)
Ohio (5)
Pennsylvania (49)
South America (7)
Southern California (62)
Tennessee (1)
Texas (29)
United States (855)
Utah (7)
Virginia (3)
Washington State (15)
Wisconsin (1)
6,763 Results for "%E2%80%9D".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IgGenix Announces Completion of Enrollment for Phase 1 Clinical Trial “ACCELERATE Peanut” with IGNX001 in Peanut Allergy
September 3, 2025
·
2 min read
Press Releases
Yellowstone Biosciences Appoints James (“Jim”) MacDonald as Chief Executive Officer
September 16, 2025
·
2 min read
Press Releases
QL Biopharm reports Phase 2 results of a monthly dose study evaluating zovaglutide, a novel, extended half-life GLP-1 receptor agonist at EASD 2025
September 18, 2025
·
6 min read
Press Releases
Acadia Pharmaceuticals Presents Clinical Data from Across Multiple Therapeutic Programs at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
October 3, 2025
·
4 min read
Press Releases
Almirall Presents Long‑Term Results from First Real‑World Dermatology Study Using WHO‑5 Well‑Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 2025
September 18, 2025
·
7 min read
Press Releases
Data from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the European Society of Medical Oncology (ESMO) Congress 2025
October 13, 2025
·
3 min read
Press Releases
Enanta Pharmaceuticals to Participate in the H.C. Wainwright & Co. “HCW@Home” Series
August 6, 2025
·
1 min read
Press Releases
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
September 1, 2025
·
14 min read
Press Releases
Ignota Labs Acquires Kronos’s Clinical Pipeline
October 6, 2025
·
2 min read
Press Releases
FORE Biotherapeutics to Host Virtual Key Opinion Leader Roundtable Discussion on Plixorafenib’s Potential to Disrupt the BRAF Market to Benefit Patients
October 14, 2025
·
3 min read
1 of 677
Next
